Skip to content
Search

Latest Stories

Call for urgent need to rectify racism disparities in pharmacy workforce

Pharmacists from BAME backgrounds still face higher levels of discrimination, harassment, bullying, and career obstacles compared to their white counterparts, the Pharmacy Workforce Race Equality Standard (PWRES) report has revealed. Published by NHSE England, this report underscores the persistent presence of inequality, emphasising the crucial need for all stakeholders in the pharmacy sector to prioritise addressing these issues.

The PWRES report indicates that pharmacy team members of Black ethnic backgrounds are less likely to perceive equal opportunities for career advancement or promotion within their trust. Additionally, female pharmacy team members from BAME backgrounds report higher incidents of personal discrimination in the workplace. The report also highlights an overrepresentation of pharmacy technicians from BAME backgrounds in lower-paid roles.


“It is shocking and unacceptable to see that across all indicators the BME staff experience is worse than their white counterparts,” said Tase Oputu, Chair of RPS in England.

“Now we have the baseline data, in-depth work must begin to tackle the issues and improve the situation. All trusts should prioritise examining their own workforce data against this report and implement an immediate action plan so we start to see real change,” added Oputu, who is also the Chair of English Pharmacy Board.

According to the PWRES findings, England had a total of 51,440 pharmacists and 20,768 pharmacy technicians as of March 2022. Among these, NHS trusts employed 11,396 pharmacists and 8,443 pharmacy technicians. During this period, 43.3 per cent (4,934) of pharmacists and 19.2 per cent (1,625) of pharmacy technicians within NHS trusts hailed from a BAME background.

Racism embedded in the workforce

The PWRES report is the first-ever comprehensive examination of the representation, discrimination, and experiences of BAME pharmacists, pharmacy technicians, and the wider pharmacy team within the NHS.

Oputu emphasised that issues of race and racism have long been entrenched in the workforce, often dismissed and overlooked, resulting in systemic disadvantages, discrimination, and harm within the workplace.

“The report provides evidence of the inequalities present across the secondary care system and I hope it will create a sea change for colleagues working in NHS as the trauma of racial abuse is finally recognised,” she added.

“It’s vital our colleagues working in primary care and community are not forgotten,” Oputu said.  “The Community Pharmacy Workforce Survey will be an opportunity to assess and report on the inequalities they face.”

The PWRES report called on pharmacy professionals and team members in community pharmacy and general practices to engage with national organizations as part of the IPP partnership, and to assess their data, taking similar action.

“It’s positive to see NHS England’s own delivery plan published alongside the report to stimulate action and drive organisational change,” said Amandeep Doll, Head of Engagement and Professional Belonging, RPS England.

“The WRES data clearly shows that BAME pharmacists are underrepresented at senior levels relative to their presence in the profession,” Doll added. “It is crucial that equal and fair opportunities for career advancement, as well as equitable treatment throughout recruitment and retention processes, are provided to each and every person in the pharmacy team.”

The ultimate goal is for employers in all environments to drive the positive changes we seek in career progression, discrimination, and racism, guaranteeing that every colleague receives the respect and fairness they deserve. This way, we harness the full potential and expertise of our diverse pharmacy workforce, the report added.

Meanwhile, the Department of Health and Social Care has recently increased travel and accommodation allowances by 50 per cent for students in several healthcare fields, but notably excluded pharmacy students. In response, three prominent pharmacy organisations, the Royal Pharmaceutical Society, British Pharmaceutical Students’ Association, and Pharmacy Schools Council, have united in urging the government to extend equal access to the NHS learning support fund (LSF) for pharmacy students, aligning with other healthcare professions.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less